Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.9 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |